Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can SLC30A8 rs13266634, KCNJ11 rs5219, and MTNRB1 rs10830963 variants reduce glucose-stimulated insulin secretion and worsen post-meal glucose handling?

These variants reduce glucose-stimulated insulin secretion, and MTNRB1 rs10830963 is also consistently linked to worse post-meal glucose handling.

PlausibleJuly 27, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

SLC30A8 rs13266634, KCNJ11 rs5219, and MTNR1B rs10830963 variants can reduce glucose-stimulated insulin secretion and worsen post-meal glucose handling.

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says these genetic variants impair pancreatic beta-cell insulin release, which can affect how the body handles glucose after eating. The mechanism framing also points to altered ion-channel activity, melatonin signaling, zinc biology, and hepatic insulin clearance as pathways behind the effect. In practice, the post-meal glucose impact appears strongest and most consistent for MTNR1B rs10830963.

Verified conclusion

Genetic variations in SLC30A8, KCNJ11, and MTNR1B significantly shape metabolic health by altering pancreatic beta-cell function. These pathways are particularly relevant for older adults, as age-related changes in glucose metabolism can compound genetic predispositions.

Impact on post-meal glucose handling

  • MTNR1B rs10830963 (G risk allele): Demonstrates a robust, direct association with impaired postprandial glucose handling. Carriers exhibit higher fasting glucose and elevated glucose excursions during oral glucose tolerance tests (OGTT), particularly during the early 30- to 60-minute phase.
  • SLC30A8 rs13266634 and KCNJ11 rs5219: While both variants are established type 2 diabetes susceptibility loci that reduce glucose-stimulated insulin secretion (GSIS), they do not consistently translate to significantly elevated postprandial blood glucose in healthy, non-diabetic populations.

Molecular and physiological mechanisms

  • Beta-cell dysfunction: These variants impair GSIS through distinct intracellular mechanisms. KCNJ11 rs5219 decreases KATP channel sensitivity to ATP, preventing the membrane depolarization required for insulin release. MTNR1B rs10830963 increases melatonin receptor expression, which actively suppresses early-phase insulin secretion.
  • Insulin clearance and zinc transport: SLC30A8 rs13266634 alters insulin granule zinc biology, leading to impaired first-phase insulin secretion. Crucially, it also modulates hepatic insulin clearance. Because less zinc is co-secreted with insulin, the liver's suppression of insulin endocytosis is reduced, resulting in accelerated insulin clearance from circulation.

Bottom line

  • All three variants impair glucose-stimulated insulin secretion, but only the MTNR1B rs10830963 variant is consistently tied to worsened post-meal glucose handling, while the metabolic impact of SLC30A8 and KCNJ11 is partially mitigated by physiological compensation in healthy individuals.

References

  1. Zinc transporter-8 gene (SLC30A8) is associated with type 2 ... — pubmed.ncbi.nlm.nih.gov ↗
  2. Polymorphisms within Novel Risk Loci for Type 2 — pmc.ncbi.nlm.nih.gov ↗
  3. SLC30A8 (ZnT8) Polymorphism is Associated with Young ... — pmc.ncbi.nlm.nih.gov ↗
  4. G-allele of intronic rs10830963 in MTNR1B confers ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Association between KCNJ11 rs5219 variant and alcohol ... — nature.com ↗
  6. G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release: Studies Involving 19,605 Europeans — diabetesjournals.org ↗
  7. Diabetes-associated Genetic Variation in MTNR1B and Its ... — academic.oup.com ↗
  8. The rs10830963 Polymorphism of the MTNR1B Gene - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. SLC30A8 mutations in type 2 diabetes — pubmed.ncbi.nlm.nih.gov ↗
  10. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→